Skip to main content
Back to Matrix Partners China

Matrix Partners China's Therapeutics Portfolio

Browse 2 Therapeutics companies funded by Matrix Partners China. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
2
Total Funding in Therapeutics
$46.0M

Therapeutics Portfolio Companies (2)

Export
BiotechnologyHealth CareMedicalOncologyPharmaceuticalTherapeutics

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Cambridge, United States
May 2023
$8.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

Cambridge, United States
January 2026
$38.0M
Series B

Founder Contacts

19,000+ verified contacts

Explore Matrix Partners China's Full Portfolio

View all companies funded by Matrix Partners China across every industry and funding stage.

View Full Matrix Partners China Portfolio